LAVAL, Quebec, July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. VRX VRX today announced that it plans to release second quarter 2017 financial results on Tuesday, Aug. 8, 2017. The Company will host a conference call and live webcast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the investor relations portion of the corporate website before the start of the conference call.
Conference Call Details
Date |
Tuesday, Aug. 8, 2017 |
Time |
8:00 a.m. EDT |
Webcast |
|
Participant Event Dial-in |
(877) 876-8393 (North America) |
(443) 961-0178 (International) | |
Participant Passcode |
35736021 |
Replay Dial-in |
(855) 859-2056 (North America) |
(404) 537-3406 (International) | |
Replay Passcode |
31833 (replay available until Oct. 8, 2017) |
About Valeant
Valeant Pharmaceuticals International, Inc. VRX is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Investor Contacts: |
||
Arthur Shannon |
Elif McDonald |
|
514-856-3855 |
514-856-3855 |
|
877-281-6642 (toll free) |
877-281-6642 (toll free) |
Media Contact: |
|
Lainie Keller |
|
908-927-0617 |
View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-announces-q2-2017-financial-results-date-and-conference-call-details-300485451.html
SOURCE Valeant Pharmaceuticals International, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.